Haemonetics (HAE) Accumulated Expenses (2010 - 2026)

Haemonetics' Accumulated Expenses history runs 17 years deep, the most recent figure standing at $68.2 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 14.76% year-over-year to $68.2 million; the TTM figure through Mar 2026 stood at $68.2 million (up 14.76% YoY), while the FY2026 annual figure was $68.2 million, up 14.76% from the prior year.
• Accumulated Expenses was $68.2 million for Q1 2026 at Haemonetics, up from $52.1 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $80.7 million in Q1 2024 to a low of $30.4 million in Q3 2022.
• Historically, Accumulated Expenses has averaged $49.8 million across 5 years, with a median of $48.4 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses jumped 33.64% in 2022, then fell 26.37% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $52.2 million in 2022, then advanced by 12.61% to $58.8 million in 2023, then decreased by 21.83% to $45.9 million in 2024, then rose by 13.42% to $52.1 million in 2025, then jumped by 30.89% to $68.2 million in 2026.
• The last three Accumulated Expenses figures came in at $68.2 million (Q1 2026), $52.1 million (Q4 2025), and $48.3 million (Q3 2025), per Business Quant data.